サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1338894

重大疾病保険市場規模、タイプ別、用途別、保険料形態別、エンドユーザー別、地域別、セグメント予測、2023年～2032年

Critical Illness Insurance Market Size, By Type (Individual Insurance, Family Insurance); By Application; By Premium Mode; By End User; By Region; Segment Forecast, 2023- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
重大疾病保険市場規模、タイプ別、用途別、保険料形態別、エンドユーザー別、地域別、セグメント予測、2023年～2032年
出版日: 2023年06月23日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の重大疾病保険市場規模は2032年までに3,765億7,000万米ドルに達する見込みです。本レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

主な促進要因の一つは、心臓発作、がん、腎不全などの重篤な疾病の増加であり、これらはしばしば不健康なライフスタイルと関連しています。さらに、保険適用の利点や保険なしでの高額な治療費に対する意識の高まりが需要の増加につながっています。また、キャッシュレス治療や一流病院での高額な医療費負担のない払い戻しなど、手間のかからない保険が利用できるようになったことも要因のひとつです。こうした保険に投資することで、危篤時の経済的保護と安心感を個人に提供することができ、市場の急成長を後押ししています。

例えば、2022年3月、ハートフォードは、より幅広い病状をカバーし、個人の診断の重篤度に応じた多様な給付金を提供する新しい重大疾病保険を発表しました。同様に、2022年12月、エイジアス・フェデラル生命保険は「クリティ・ケア・プラン」を発表しました。このプランは、高額な治療費や回復費用の補償を含む重大疾病給付を契約者に提供するものです。

さらに、医療費の高騰が市場を牽引しています。重病に関連する医療費は、保険が適用されないとすぐに手に負えなくなるからです。重大疾病保険はこうした費用を軽減するのに役立ち、契約者は深刻な健康問題が発生した場合でも保護されているという安心感を得ることができます。ヘルスケア費用が増加の一途をたどる中、病気の経済的負担を軽減する手段としてこの保険を利用する人が増えています。

さらに、市場成長の原動力となっているのは、競争が激化してイノベーションが進み、消費者にとってより価値の高い保険が提供されるようになったインシュアテック企業の台頭などの要因です。医療技術や治療法の進歩により、重篤な病気の生存率が高まり、回復期の経済的支援の必要性が生じています。さらに、従業員に健康保険の適用を義務付ける政府の規制も、市場の拡大に寄与しています。

重大疾病保険市場レポート・ハイライト

個人保険セグメントが市場を独占しているが、その理由は様々な施設に対応しているためです。個人保険は一般的に保障限度額、保険料、給付金の面で柔軟性が高いです。

がん分野は、死亡や障害の原因となる広範な疾病であるため、最大の収益シェアを占め、業界をリードしています。

月払保険料分野は、その手頃な価格、柔軟性、顧客維持能力、競合優位性から、かなりの収益シェアを占めると予測されます。

北米は、慢性疾患の有病率の増加と医療保険の重要性に対する意識の高まりにより、世界市場を独占しています。

世界市場の主要プレーヤーは、エイゴン、アフラック、アリアンツ・ケア、アメリカン・インターナショナル、アヴィバ、アクサ、バジャイ・アリアンツ、シグナ、フューチャー・ジェネラリです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の重症疾病保険市場に関する洞察

  • 重大疾病保険市場- 保険料形態のスナップショット
  • 重大疾病保険市場力学
    • 促進要因と機会
      • 健康問題の増加
      • 重大疾病保険契約でカバーされる重篤な病気の範囲の拡大
    • 抑制要因と課題
      • 高コスト
  • PESTEL分析
  • 重大疾病保険市場の保険料形態の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の重症疾病保険市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 個人保険
  • 家族保険

第6章 世界の重症疾病保険市場、疾患別

  • 主な調査結果
  • イントロダクション
  • がん
  • 心臓発作
  • 脳卒中
  • その他の用途

第7章 世界の重症疾病保険市場、保険料形態別

  • 主な調査結果
  • イントロダクション
  • 月次
  • 四半期
  • 半期
  • 年次

第8章 世界の重症疾病保険市場、地域別

  • 主な調査結果
  • イントロダクション
    • 重大疾病保険市場の評価、地域別、2019～2032年
  • 重大疾病保険市場-北米
    • 北米：重大疾病保険市場、タイプ別、2019～2032年
    • 北米：重大疾病保険市場、保険料形態別、2019～2032年
    • 北米：重大疾病保険市場、疾病別、2019～2032年
    • 重大疾病保険市場-米国
    • 重大疾病保険市場- カナダ
  • 重大疾病保険市場- 欧州
    • 欧州：重大疾病保険市場、タイプ別、2019～2032年
    • 欧州：重大疾病保険市場、保険料形態別、2019～2032年
    • 欧州：重大疾病保険市場、疾病別、2019～2032年
    • 重大疾病保険市場- 英国
    • 重大疾病保険市場- フランス
    • 重大疾病保険市場- ドイツ
    • 重大疾病保険市場- イタリア
    • 重大疾病保険市場- スペイン
    • 重大疾病保険市場- オランダ
    • 重大疾病保険市場- ロシア
  • 重大疾病保険市場- アジア太平洋
    • アジア太平洋：重大疾病保険市場、タイプ別、2019～2032年
    • アジア太平洋：重大疾病保険市場、保険料形態別、2019～2032年
    • アジア太平洋：重大疾病保険市場、疾病別、2019～2032年
    • 重大疾病保険市場- 中国
    • 重大疾病保険市場- インド
    • 重大疾病保険市場- マレーシア
    • 重大疾病保険市場- 日本
    • 重大疾病保険市場- インドネシア
    • 重大疾病保険市場- 韓国
  • 重大疾病保険市場-中東およびアフリカ
    • 中東およびアフリカ：重大疾病保険市場、タイプ別、2019～2032年
    • 中東およびアフリカ：重大疾病保険市場、保険料形態別、2019～2032年
    • 中東およびアフリカ：重大疾病保険市場、疾病別、2019～2032年
    • 重大疾病保険市場- サウジアラビア
    • 重大疾病保険市場- アラブ首長国連邦
    • 重大疾病保険市場- イスラエル
    • 重大疾病保険市場- 南アフリカ
  • 重大疾病保険市場-ラテンアメリカ
    • ラテンアメリカ：重大疾病保険市場、タイプ別、2019～2032年
    • ラテンアメリカ：重大疾病保険市場、保険料形態別、2019～2032年
    • ラテンアメリカ：重大疾病保険市場、疾病別、2019～2032年
    • 重大疾病保険市場- メキシコ
    • 重大疾病保険市場- ブラジル
    • 重大疾病保険市場- アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Aegon
  • AFLAC
  • Allianz Care
  • American International
  • Aviva
  • AXA
  • Bajaj Allianz
  • Cigna
  • Future Generali
  • Liberty Mutual Insurance
  • MetLife Services
  • Royal London
  • Sun Life Assurance
  • United HealthCare
  • Modern Insurance
  • Plum Benefits
図表

List of Tables

  • Table 1 Global Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 3 Global Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 4 Critical Illness Insurance Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 7 North America: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 8 U.S.: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 10 U.S.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 11 Canada: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 13 Canada: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 14 Europe: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 16 Europe: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 17 UK: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 19 UK: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 20 France: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 22 France: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 23 Germany: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 25 Germany: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 26 Italy: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 28 Italy: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 29 Spain: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 31 Spain: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 35 Russia: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 37 Russia: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 41 China: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 43 China: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 44 India: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 46 India: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 50 Japan: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 52 Japan: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 56 South Korea: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 58 South Korea: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 65 UAE: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 67 UAE: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 68 Israel: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 70 Israel: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 71 South Africa: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 73 South Africa: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 74 Latin America: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 76 Latin America: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 77 Mexico: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 79 Mexico: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 80 Brazil: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 82 Brazil: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • Table 83 Argentina: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • Table 85 Argentina: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Critical Illness Insurance Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Disease
  • Figure 7. Global Critical Illness Insurance Market, by Disease, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Critical Illness Insurance Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Premium Mode
  • Figure 11. Global Critical Illness Insurance Market, by Premium Mode, 2022 & 2032 (USD Billion)
  • Figure 12. Critical Illness Insurance Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Critical Illness Insurance Market
目次
Product Code: PM3338

The global critical illness insurance market size is expected to reach USD 376.57 billion by 2032, according to a new study by Polaris Market Research. The report "Critical Illness Insurance Market Size, By Type (Individual Insurance, Family Insurance); By Application; By Premium Mode; By End Use; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

One of the primary driver is the increase in serious illnesses, such as heart attacks, cancer, and kidney failures, which are often linked to unhealthy lifestyles. Additionally, increased awareness of the benefits of insurance coverage and the high cost of treatment without insurance has led to a rise in demand. Another factor is the availability of hassle-free coverage, including cashless treatments and medical bill reimbursements at top hospitals without high fees. Investing in these insurance can provide individuals with financial protection and peace of mind during critical illness, driving market growth at a rapid pace.

For instance, in March 2022, the Hartford introduced a new critical illness insurance policy that provides coverage for a wider range of medical conditions and offers diverse benefits based on the severity of the diagnosis for an individual. Similarly, in December 2022, the Ageas Federal Life Insurance introduced its "Criti Care Plan". This plan offers critical illness benefits to policyholders, including coverage for expensive treatment costs and recovery expenses.

Moreover, rising healthcare costs are driving the market, as medical expenses related to critical illnesses can quickly become unmanageable without insurance coverage. Critical illness insurance helps alleviate these costs, providing policyholders with peace of mind knowing that they are protected in the event of a serious health issue. As healthcare costs continue to increase, more individuals are turning to this insurance as a means of managing the financial burden of illnesses.

Furthermore, market growth is also driven by factors including rise of insurtech companies which has created more competition, leading to greater innovation and better value for consumers. Advances in medical technology and treatments have resulted in higher survival rates for critical illnesses, creating a need for financial support during recovery periods. Additionally, government regulations mandating health insurance coverage for employees are also contributing to the expansion of the market.

Critical Illness Insurance Market Report Highlights

The individual insurance segment dominated the market owing to various facilities includes individual policies are typically more flexible in terms of coverage limits, premiums, and benefits.

Cancer segment led the industry with a holding of largest revenue share because it is a widespread disease which causing deaths and disabilities.

The monthly premium segment is projected to account for a substantial revenue share due to its affordability, flexibility, ability to retain customers, and competitive advantage.

North America dominates the global market due to the increasing prevalence of chronic diseases, and an increasing awareness of the importance of health insurance.

Major players in the global market are Aegon, AFLAC, Allianz Care, American International, Aviva, AXA, Bajaj Allianz, Cigna, and Future Generali.

Polaris Market Research has segmented the Critical Illness Insurance Market report based on Type, Application, Premium Mode, and Region:

Critical Illness Insurance Market, By Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Individual Insurance
  • Family Insurance

Critical Illness Insurance Market, By Application Outlook (Revenue - USD Billion, 2023 - 2032)

  • Cancer
  • Heart Attack
  • Stroke
  • Other Applications

Critical Illness Insurance Market, By Premium Mode Outlook (Revenue - USD Billion, 2023 - 2032)

  • Monthly
  • Quarterly
  • Half Yearly
  • Yearly

Critical Illness Insurance Market, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Critical Illness Insurance Market Insights

  • 4.1. Critical Illness Insurance Market - Premium Mode Snapshot
  • 4.2. Critical Illness Insurance Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising number of health issues
      • 4.2.1.2. Increase in the range of critical illnesses covered in critical illness insurance policies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Critical Illness Insurance Market Premium Mode Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Critical Illness Insurance Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Individual Insurance
    • 5.3.1. Global Critical Illness Insurance Market, by Individual Insurance, by Region, 2019-2032 (USD Billion)
  • 5.4. Family Insurance
    • 5.4.1. Global Critical Illness Insurance Market, by Family Insurance, by Region, 2019-2032 (USD Billion)

6. Global Critical Illness Insurance Market, by Disease

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • 6.3. Cancer
    • 6.3.1. Global Critical Illness Insurance Market, by Cancer, by Region, 2019-2032 (USD Billion)
  • 6.4. Heart Attack
    • 6.4.1. Global Critical Illness Insurance Market, by Heart Attack, by Region, 2019-2032 (USD Billion)
  • 6.5. Stroke
    • 6.5.1. Global Critical Illness Insurance Market, by Stroke, by Region, 2019-2032 (USD Billion)
  • 6.6. Other Applications
    • 6.6.1. Global Critical Illness Insurance Market, by Other Applications, by Region, 2019-2032 (USD Billion)

7. Global Critical Illness Insurance Market, by Premium Mode

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
  • 7.3. Monthly
    • 7.3.1. Global Critical Illness Insurance Market, by Monthly, By Region, 2019-2032 (USD Billion)
  • 7.4. Quarterly
    • 7.4.1. Global Critical Illness Insurance Market, by Quarterly, By Region, 2019-2032 (USD Billion)
  • 7.5. Half Yearly
    • 7.5.1. Global Critical Illness Insurance Market, by Half Yearly, By Region, 2019-2032 (USD Billion)
  • 7.6. Yearly
    • 7.6.1. Global Critical Illness Insurance Market, by Yearly, By Region, 2019-2032 (USD Billion)

8. Global Critical Illness Insurance Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Critical Illness Insurance Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Critical Illness Insurance Market - North America
    • 8.3.1. North America: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
    • 8.3.3. North America: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.3.4. Critical Illness Insurance Market - U.S.
      • 8.3.4.1. U.S.: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.3.5. Critical Illness Insurance Market - Canada
      • 8.3.5.1. Canada: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • 8.4. Critical Illness Insurance Market - Europe
    • 8.4.1. Europe: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.4.4. Critical Illness Insurance Market - UK
      • 8.4.4.1. UK: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.4.5. Critical Illness Insurance Market - France
      • 8.4.5.1. France: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.4.6. Critical Illness Insurance Market - Germany
      • 8.4.6.1. Germany: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.4.7. Critical Illness Insurance Market - Italy
      • 8.4.7.1. Italy: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.4.8. Critical Illness Insurance Market - Spain
      • 8.4.8.1. Spain: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.4.9. Critical Illness Insurance Market - Netherlands
      • 8.4.9.1. Netherlands: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.4.10. Critical Illness Insurance Market - Russia
      • 8.4.10.1. Russia: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • 8.5. Critical Illness Insurance Market - Asia Pacific
    • 8.5.1. Asia Pacific: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.5.4. Critical Illness Insurance Market - China
      • 8.5.4.1. China: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.5.5. Critical Illness Insurance Market - India
      • 8.5.5.1. India: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.5.6. Critical Illness Insurance Market - Malaysia
      • 8.5.6.1. Malaysia: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.5.7. Critical Illness Insurance Market - Japan
      • 8.5.7.1. Japan: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.5.8. Critical Illness Insurance Market - Indonesia
      • 8.5.8.1. Indonesia: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.5.9. Critical Illness Insurance Market - South Korea
      • 8.5.9.1. South Korea: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • 8.6. Critical Illness Insurance Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.6.4. Critical Illness Insurance Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.6.5. Critical Illness Insurance Market - UAE
      • 8.6.5.1. UAE: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.6.6. Critical Illness Insurance Market - Israel
      • 8.6.6.1. Israel: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.6.7. Critical Illness Insurance Market - South Africa
      • 8.6.7.1. South Africa: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
  • 8.7. Critical Illness Insurance Market - Latin America
    • 8.7.1. Latin America: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.7.4. Critical Illness Insurance Market - Mexico
      • 8.7.4.1. Mexico: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.7.5. Critical Illness Insurance Market - Brazil
      • 8.7.5.1. Brazil: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)
    • 8.7.6. Critical Illness Insurance Market - Argentina
      • 8.7.6.1. Argentina: Critical Illness Insurance Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Critical Illness Insurance Market, by Premium Mode, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Critical Illness Insurance Market, by Disease, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Aegon
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AFLAC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Allianz Care
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. American International
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Aviva
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. AXA
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Bajaj Allianz
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Cigna
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Future Generali
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Liberty Mutual Insurance
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. MetLife Services
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Royal London
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sun Life Assurance
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. United HealthCare
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Modern Insurance
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Plum Benefits
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development